EUVIMEDEUVIMED entdecken
Open Access

State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care

Mark K Meiselbach iD, Coleman Drake iD, Jane M Zhu, Brynna Manibusan, Dylan Nagy, Mark J Sorbero, Brendan Saloner, Bradley D Stein, Daniel Polsky iD

Medical Care Research and Review · 2023-08 · 80 (4) · 423-432

DOI: 10.1177/10775587231167514 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Care Research and Review, online erschienen am 21.04.2023. Verfasst von Mark K Meiselbach und 8 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Buprenorphine, Opioid-Related Disorders. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Provider networks in Medicaid Managed Care (MMC) play a crucial role in ensuring access to buprenorphine, a highly effective treatment for opioid use disorder. Using a difference-in-differences approach that compares network breadth across provider specialties and market segments within the same state, we investigated the association between three Medicaid policies and the breadth of MMC networks for buprenorphine prescribers: Medicaid expansion, substance use disorder (SUD) network adequacy criteria, and SUD carveouts. We found that both Medicaid expansion and SUD network adequacy criteria were associated with substantially increased breadth in buprenorphine-prescriber networks in MMC. In both cases, we found that the associations were largely driven by increases in the network breadth of primary care physician prescribers. Our findings suggest that Medicaid expansion and SUD network adequacy criteria may be effective strategies at states’ disposal to improve access to buprenorphine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BuprenorphineOpioid-Related DisordersUnited StatesHumansMedicaidPolicyOpiate Substitution Treatment

Stichwörter der Autor:innen

Medicaid managed careMedicaid policybuprenorphineopioid use disorderprovider networks

Substanzen

Buprenorphine

Autor:innen und Institutionen

  • Johns Hopkins University, Baltimore, MD, USA.
  • University of Pittsburgh, PA, USA.
  • Oregon Health & Science University, Portland, USA.
  • RAND Corporation, Pittsburgh, PA, USA.

ORCID-Profile: Mark K Meiselbach, Coleman Drake, Daniel Polsky

Förderung

  • NIDA NIH HHS
  • NIMH NIH HHS
  • National Institute of Mental Health
  • National Institute on Drug Abuse
  • Arnold Ventures

Zitieren

APA

Meiselbach, M. K., Drake, C., Zhu, J. M., Manibusan, B., Nagy, D., Sorbero, M. J., Saloner, B., Stein, B. D., & Polsky, D. (2023). State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care. Medical Care Research and Review, 80(4), 423-432. https://doi.org/10.1177/10775587231167514

Vancouver

Meiselbach MK, Drake C, Zhu JM, Manibusan B, Nagy D, Sorbero MJ, et al. State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care. Medical Care Research and Review. 2023;80(4):423-432. doi:10.1177/10775587231167514

BibTeX
@article{Meiselbach2023,
  author = {Meiselbach, Mark K and Drake, Coleman and Zhu, Jane M and Manibusan, Brynna and Nagy, Dylan and Sorbero, Mark J and Saloner, Brendan and Stein, Bradley D and Polsky, Daniel},
  title = {State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care},
  journal = {Medical Care Research and Review},
  year = {2023},
  volume = {80},
  number = {4},
  pages = {423--432},
  doi = {10.1177/10775587231167514}
}
Kostenlos starten →